Nuviun
Register with nuviun FREE Log in
Register with nuviun Log in
  • digital health
    • Big Data
    • eHealth
    • EHR - EMR
    • Gamification
    • Health 2.0-Social Media in Healthcare
    • Health and Wellness Apps
    • Health IT
    • Interoperability
    • Medical Imaging
    • mHealth
    • Personal Genomics
    • Quantified Self
    • Sensors and Wearables
    • Telehealth/Telemedicine/Connected Health
    • Betting Sites UK
  • content library
    • Series
  • dashboard
  • directory
    • people
    • companies
  • events
nuviun
Content library
Today’s Stress Might Be Tomorrow’s Depression

Today’s Stress Might Be Tomorrow’s Depression

Published 04/02/2015 at 00:00 Jenn Lonzer, MA Personal Genomics Genomics Personalized Medicine Chronic Disease United States 0 comments
Today’s Stress Might Be Tomorrow’s Depression

A new study finds that the way the brain processes stressful situations correlates with future vulnerability to the development of depression and anxiety.

If you could look into the future and see where you’ll be in 3 years, would you? If you knew that, several years from now, memories of an illness, accident, or the death of a loved one might lead to depression and anxiety, would you do anything differently?

There’s no magic-8-ball app for this yet. However, scientists from Duke University have discovered a new strategy for predicting if an individual is at increased risk of developing depression or anxiety following stressful life events.

The Duke research team reports in the journal Neuron, today, a link between how college students respond to angry or fearful images and their ability to manage stressful situations later in life.

“Our results indicate that the response of the amygdala to threatening faces may serve as a biomarker that could indicate risk for the development of depression and anxiety in response to stress,” lead author Johnna Swartz told nuviun. “Thus, this biomarker could be used to guide individuals to seek treatment early if they encounter major stressful life events, and potentially prevent the onset of a more chronic, difficult-to-treat disorder.”

Depression Affects 400 Million Worldwide

Source: darcyadelaide (Flickr: CC)

Depression, according to the World Health Organization (WHO), is a disorder characterized by sadness, loss of interest, feelings of guilt, low self-worth, sleep disruptions, and difficulty concentrating. Depression can impair an individual’s ability to cope with life stressors, to hold a job, and even to get out of bed. At its worst, depression can lead to suicide.

Mental illness, including depression and anxiety disorders, has a significant effect on the lives of many around the word. Approximately 400 million individuals suffer from some form of depression globally, according to the World Health Organization.

The statistics are quite significant. In the United States and the Middle East, 1 in 10 people report episodes of depression. In Canada, nearly 1 in 8 people have depression, while 1 in 5 people have mental illness or substance abuse. In Europe, 1 in 10 people have taken time away from work because of depression.

Investigators showed threatening photographs to 753 college-aged participants, all of whom reported being free of depression and anxiety at the time of the study. Using functional magnetic resonance imaging (fMRI), the research team was able to measure participants’ amygdala reactivity.  

The strength of the amygdala's response to threatening faces predicts psychological responses to stress in the future. (Source: Annchen Knodt/Neuron 2015)

The fMRI is a non-invasive method of measuring brain activity that helps neuroscientists understand how the healthy brain works, and how diseases, including mood disorders like depression and anxiety, can disrupt that brain activity.

According to the study, greater amygdala reactivity to common stressors could lead some participants to react more strongly to stressful situations than others. They might even remember events differently. This altered stress response is a key symptom of depression and anxiety disorders.

After establishing baseline levels of amygdala reactivity for each participant, investigators sent online surveys at three-month intervals to assess participants’ current mood and current life stressors. Symptoms of depression and anxiety were also recorded.

Predicting Depression and Anxiety

Results indicate that baseline threat-related amygdala reactivity predicts psychological vulnerability to common life stressors in the future. Participants with relatively heightened levels at baseline reported more symptoms of depression and anxiety at follow-up.

This relationship between baseline amygdala reactivity and resilience to life stressors (e.g., the death of a loved one, a car accident, a significant illness, a job change) was shown to last 1-4 years. These college students’ reactions to pictures of angry or sad faces impacted their ability to recover from break-ups, lay-offs, and credit card bills in the future.

Would You Want to Know?

The investigators identified a predictive biological marker of risk for the development of depression and anxiety. But I wonder: would you want to know if you would likely suffer from clinical depression in the next few years? Is there any way to reduce reactivity to stressors in order to prevent or lessen the severity of future mental illness?

Yes, according to Dr. Swartz, who was more than happy to address nuviun’s question:

“Both pharmacological treatments (e.g., selective-serotonin reuptake inhibitors) as well as therapies (e.g., cognitive behavioral therapy) have been shown to reduce amygdala reactivity to threat.  Moreover, using real-time fMRI biofeedback shows participants their amygdala response during an fMRI scan. Studies have demonstrated that individuals can learn to reduce their amygdala reactivity using this fMRI biofeedback.”

The fMRI is an expensive test, though. Now that Swartz’s team has identified the predictive marker of risk, the next step is to find a less expensive method to identify patients’ baseline amygdala reactivity levels.

“One of the next steps of our research,” Swartz told nuviun, “is to identify genes that predict heightened amygdala reactivity to threat. It is much more cost effective to obtain DNA from a saliva sample than to perform an fMRI scan; thus, identifying genes that predict amygdala reactivity could provide a less expensive screening tool to aid in assessing individuals' future risk for the development of depression and anxiety.”

 

Log in or register for FREE for full access to ALL site features

As a member of the nuviun community, you can benefit from:

  • 24/7 unlimited access to the content library
  • Full access to the company and people directories
  • Unlimited discussion and commenting privileges
  • Your own searchable professional profile

Not yet a member?

Register now

Already a member?

Log in for immediate access:

Login failed, check your credentials and try again.

Author:

Jenn Lonzer, MA
Jenn Lonzer, MA View profile
Categorised:

Categorised:

  • Personal Genomics
  • Genomics
  • Personalized Medicine
  • Chronic Disease
  • United States
Share with friends and colleagues
Discuss this post You must be logged in to comment on this post.
  • Most popular
  • Most recent
  • Today’s Stress Might Be Tomorrow’s Depression

  • 5 major digital health trends we will see in 2015

  • “The patient will see you now” – big data empowers patients, flips the healthcare model

  • Did Wearable Technology Fail Again at CES 2015?

  • Healthcare and Health IT in 2015. What the world needs now is...simplicity

  • Global Digital Diet Tools: The Best Weight Loss App Is One You’ll Use

  • UAE Commits US $1 Million for Prosthetics in War-Torn Syria

  • Wildly Successful #Bell Let’s Talk Day Proves the Power of Social Media for Health Communication

  • Did Wearable Technology Fail Again at CES 2015?

  • Global Digital Diet Tools: The Best Weight Loss App Is One You’ll Use

  • A Geography of Cancer

  • Today’s Stress Might Be Tomorrow’s Depression

More by this author
  • UAE Commits US $1 Million for Prosthetics in War-Torn Syria

  • Wildly Successful #Bell Let’s Talk Day Proves the Power of Social Media for Health Communication

  • Global Digital Diet Tools: The Best Weight Loss App Is One You’ll Use

  • Today’s Stress Might Be Tomorrow’s Depression

    A Geography of Cancer

  • Smartphones may Predict Stroke with Samsung’s Wearable Stroke Sensor

Related posts
  • Today’s Stress Might Be Tomorrow’s Depression

    A Geography of Cancer

  • Global Digital Diet Tools: The Best Weight Loss App Is One You’ll Use

  • Qatar's Innovative Health Education Campaign, Sahtak Awalan, to Be Showcased at WISH 2015

  • Today’s Stress Might Be Tomorrow’s Depression

    Neuroscientists Use Optogenetics and Implantable Device to Better Understand Compulsive Overeating

  • Today’s Stress Might Be Tomorrow’s Depression

    Manna in the Cloud: Solving Africa’s Undernutrition Problem One Genome Sequence at a Time

  • Personalised prevention: Where is it?

Explore nuviun
  • Home
  • About nuviun
  • Join our team
  • Contact nuviun
  • Site map
  • Privacy and cookies
  • Terms and conditions
Dashboard
  • Dashboard
  • Content Library
  • Subscriptions
  • Directory
  • Edit profile
  • My account
Connect with us
facebook linkedin twitter
© 2015 Nuviun. All rights reserved. MintTwist CMS Websites

nuviun.com uses cookies to enhance your experience. By using this site you agree to have cookies placed on your computer. To learn more, please see our cookies policy and privacy policy pages. Thanks for reading.

Apologies

These features are reserved for registered users of nuviun.com. Registration is FREE.

It's simple to:

  • log in if you've already registered
  • or super quick to register a new account if you don't have one yet.
Log inRegister with nuviun

You have unfavourited the article [title]